Compare Natera Inc. Common Stock (NTRA) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Rush Street Interactive Inc — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while Rush Street Interactive Inc trades at $18.31 (market cap $2.14B). The key difference: Natera Inc. Common Stock is far larger — about 26.6× Rush Street Interactive Inc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Rush Street Interactive Inc for 13 Days on average.
| NTRA | RSI | |
|---|---|---|
Market Cap | $57.03B | $2.14B |
Volume | 1,131,157 | 1,828,735 |
Sector | Health | Consumer Cyclical |
52-Week High | $425.64 | $34.52 |
52-Week Low | $179.42 | $15.89 |
Typical Hold Time | 0 Days | 13 Days |
Enterprise Value | $56.18B | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
RSI trades at $19.07, up 1.92% with bearish technical signals but strong analyst support. The company shows revenue growth to $1.13B in 2025 with improving cash flow, though net margins remain thin at 2.33%. Recent Q2 2026 earnings beat expectations at $0.15 EPS, while institutional interest grows with BlackRock's $448M investment in August 2026.
Outlook remains positive with 77% analyst buy ratings and $33.75 price target offering 77% upside. Key risks include competitive pressures in online gaming and margin compression. The stock presents growth potential but requires monitoring of profitability trends and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
